Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 237

1.

Thalidomide in low intermittent doses does not prevent recurrence of human immunodeficiency virus-associated aphthous ulcers.

Jacobson JM, Greenspan JS, Spritzler J, Fox L, Fahey JL, Jackson JB, Chernoff M, Wohl DA, Pulvirenti JJ, Hooton TM, Shikuma C.

J Infect Dis. 2001 Jan 15;183(2):343-346. Epub 2000 Dec 15.

PMID:
11120935
[PubMed - indexed for MEDLINE]
Free Article
2.

Thalidomide for the treatment of esophageal aphthous ulcers in patients with human immunodeficiency virus infection. National Institute of Allergy and Infectious Disease AIDS Clinical Trials Group.

Jacobson JM, Spritzler J, Fox L, Fahey JL, Jackson JB, Chernoff M, Wohl DA, Wu AW, Hooton TM, Sha BE, Shikuma CM, MacPhail LA, Simpson DM, Trapnell CB, Basgoz N.

J Infect Dis. 1999 Jul;180(1):61-7.

PMID:
10353862
[PubMed - indexed for MEDLINE]
Free Article
3.

Thalidomide for the treatment of oral aphthous ulcers in patients with human immunodeficiency virus infection. National Institute of Allergy and Infectious Diseases AIDS Clinical Trials Group.

Jacobson JM, Greenspan JS, Spritzler J, Ketter N, Fahey JL, Jackson JB, Fox L, Chernoff M, Wu AW, MacPhail LA, Vasquez GJ, Wohl DA.

N Engl J Med. 1997 May 22;336(21):1487-93.

PMID:
9154767
[PubMed - indexed for MEDLINE]
Free Article
4.

Thalidomide effective for oral ulcers.

[No authors listed]

Posit Aware. 1996 Jan-Feb;7(1):5.

PMID:
11363120
[PubMed - indexed for MEDLINE]
5.

Thalidomide: an alternative therapy for treatment of apthous ulcers (canker sores).

Manesis DA.

STEP Perspect. 1995 Spring;7(1):16-7.

PMID:
11362397
[PubMed - indexed for MEDLINE]
6.

Thalidomide as therapy for human immunodeficiency virus-related oral ulcers: a double-blind placebo-controlled clinical trial.

Ramirez-Amador VA, Esquivel-Pedraza L, Ponce-de-Leon S, Reyes-Teran G, Gonzalez-Guevara M, Ponce-de-Leon S, Sierra-Madero JG.

Clin Infect Dis. 1999 Apr;28(4):892-4.

PMID:
10825055
[PubMed - indexed for MEDLINE]
Free Article
7.

Thalidomide as treatment of refractory aphthous ulceration related to human immunodeficiency virus infection.

Paterson DL, Georghiou PR, Allworth AM, Kemp RJ.

Clin Infect Dis. 1995 Feb;20(2):250-4.

PMID:
7742424
[PubMed - indexed for MEDLINE]
8.

Thalidomide for aphthous ulcers in patients infected with the human immunodeficiency virus.

Weidle PJ.

Am J Health Syst Pharm. 1996 Feb 15;53(4):368, 371-2, 378. Review. No abstract available.

PMID:
8673657
[PubMed - indexed for MEDLINE]
9.

Thalidomide effective treatment for AIDS-related mouth ulcers.

Randall P.

NIAID AIDS Agenda. 1995 Dec:2.

PMID:
11363350
[PubMed - indexed for MEDLINE]
10.

Pharmacokinetics and pharmacodynamics of thalidomide in HIV patients treated for oral aphthous ulcers: ACTG protocol 251. AIDS Clinical Trials Group.

Aweeka F, Trapnell C, Chernoff M, Jayewardene A, Spritzler J, Bellibas SE, Lizak P, Jacobson J.

J Clin Pharmacol. 2001 Oct;41(10):1091-7.

PMID:
11583477
[PubMed - indexed for MEDLINE]
11.

Thalidomide: current and potential clinical applications.

Calabrese L, Fleischer AB.

Am J Med. 2000 Apr 15;108(6):487-95. Review.

PMID:
10781782
[PubMed - indexed for MEDLINE]
12.

The effect of thalidomide on the pathogenesis of human immunodeficiency virus type 1 and M. tuberculosis infection.

Klausner JD, Makonkawkeyoon S, Akarasewi P, Nakata K, Kasinrerk W, Corral L, Dewar RL, Lane HC, Freedman VH, Kaplan G.

J Acquir Immune Defic Syndr Hum Retrovirol. 1996 Mar 1;11(3):247-57.

PMID:
8603261
[PubMed - indexed for MEDLINE]
13.

Recurrent aphthous ulcer in patient infected with human immunodeficiency virus: successful treatment with thalidomide.

Radeff B, Kuffer R, Samson J.

J Am Acad Dermatol. 1990 Sep;23(3 Pt 1):523-5. No abstract available.

PMID:
2212162
[PubMed - indexed for MEDLINE]
14.

Use of thalidomide for severe recurrent aphthous stomatitis: a multicenter cohort analysis.

Hello M, Barbarot S, Bastuji-Garin S, Revuz J, Chosidow O.

Medicine (Baltimore). 2010 May;89(3):176-82. doi: 10.1097/MD.0b013e3181dfca14.

PMID:
20453604
[PubMed - indexed for MEDLINE]
15.

Thalidomide pros and cons.

[No authors listed]

Am J Nurs. 1998 Apr;98(4):63. No abstract available.

PMID:
9556688
[PubMed - indexed for MEDLINE]
16.

Safety, tolerability, and pharmacokinetic effects of thalidomide in patients infected with human immunodeficiency virus: AIDS Clinical Trials Group 267.

Wohl DA, Aweeka FT, Schmitz J, Pomerantz R, Cherng DW, Spritzler J, Fox L, Simpson D, Bell D, Holohan MK, Thomas S, Robinson W, Kaplan G, Teppler H; National Institute of Allergy and Infectious Diseases AIDS Clinical Trials Group 267.

J Infect Dis. 2002 May 1;185(9):1359-63. Epub 2002 Apr 16.

PMID:
12001058
[PubMed - indexed for MEDLINE]
Free Article
17.

Crossover study of thalidomide vs placebo in severe recurrent aphthous stomatitis.

Revuz J, Guillaume JC, Janier M, Hans P, Marchand C, Souteyrand P, Bonnetblanc JM, Claudy A, Dallac S, Klene C, et al.

Arch Dermatol. 1990 Jul;126(7):923-7.

PMID:
2193629
[PubMed - indexed for MEDLINE]
18.

Thalidomide for mouth ulcers and wasting.

Baker R.

BETA. 1995 Dec:8.

PMID:
11363016
[PubMed - indexed for MEDLINE]
19.

Efficacy of rebamipide as adjunctive therapy in the treatment of recurrent oral aphthous ulcers in patients with Beh├žet's disease: a randomised, double-blind, placebo-controlled study.

Matsuda T, Ohno S, Hirohata S, Miyanaga Y, Ujihara H, Inaba G, Nakamura S, Tanaka S, Kogure M, Mizushima Y.

Drugs R D. 2003;4(1):19-28.

PMID:
12568631
[PubMed - indexed for MEDLINE]
20.

Thalidomide in the management of recurrent aphthous ulcerations in patients who are HIV-positive: a review and case reports.

Shetty K.

Spec Care Dentist. 2005 Sep-Oct;25(5):236-41. Review.

PMID:
16454100
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk